IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ

PLoS One. 2013;8(2):e56045. doi: 10.1371/journal.pone.0056045. Epub 2013 Feb 8.

Abstract

IL-34 is a recently identified cytokine that signals via the M-CSF receptor and promotes monocyte survival. Depending on the environment, monocytes can differentiate into macrophages (Mφ) or dendritic cells (DC). A wide spectrum of Mφ and DC subsets, with distinct phenotypes and functions, has been described. To date, the phenotype of monocytes exposed to IL-34 remains unexplored. We report here that IL-34 induces the differentiation of monocytes into CD14(high) CD163(high) CD1a(-) Mφ (IL-34-Mφ). Upon LPS stimulation, IL-34-Mφ exhibit an IL-10(high) IL-12(low) M2 profile and express low levels of the costimulatory molecules CD80 and CD86. IL-34-Mφ exhibit poor T cell costimulatory properties, and have potent immunosuppressive properties (decrease of TCR-stimulated T cell proliferation). For all the parameters analyzed, IL-34-Mφ are phenotypically and functionally similar to M-CSF-Mφ. IL-34 appears as efficient as M-CSF in inducing the generation of immunosuppressive Mφ. Moreover, the generation of IL-34-Mφ is mediated through the M-CSF receptor, is independent of endogenous M-CSF consumption and is potentiated by IL-6. In an attempt to identify strategies to prevent a deleterious M2 cell accumulation in some pathological situations, we observed that IFNγ and GM-CSF prevent the generation of immunosuppressive Mφ induced by IL-34. IFNγ also switches established IL-34-Mφ into immunostimulatory Mφ. In conclusion, we demonstrate that IL-34 drives the differentiation of monocytes into immunosuppressive M2, in a manner similar to M-CSF, and that IFNγ and GM-CSF prevent this effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects*
  • Cell Differentiation / immunology
  • Chemokines / genetics
  • Cluster Analysis
  • Gene Expression Profiling
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Humans
  • Interferon-gamma / pharmacology*
  • Interleukin-10 / biosynthesis
  • Interleukin-12 / biosynthesis
  • Interleukins / pharmacology*
  • Macrophages / cytology*
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Monocytes / cytology*
  • Monocytes / drug effects*
  • Monocytes / immunology
  • Phenotype
  • Receptor, Macrophage Colony-Stimulating Factor / metabolism
  • Receptors, Chemokine / genetics

Substances

  • Chemokines
  • IL34 protein, human
  • Interleukins
  • Receptors, Chemokine
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Receptor, Macrophage Colony-Stimulating Factor

Grants and funding

This work was supported by institutional grants from INSERM (Institut national de la santé et de la recherche médicale) and the University of Angers and by a grant from La ligue contre le Cancer (Equipe labellisée 2012–2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.